A 58-gene pan-cancer panel with combined DNA content, utilizing the single-tube SLIMamp workflow for fast library prep and turnaround time.
Assay time
Hands-on time
Input quantity
The oncoReveal Myeloid Panel is a DNA NGS sequencing panel using proprietary Stem-Loop Inhibition-Mediated amplification (SLIMamp) technology, a tiled amplicon-based library prep chemistry for efficient single-tube target enrichment.
| Assay time | 48 hours sample to report |
|---|---|
| Cancer type | Hematologic |
| Description | 58-gene amplicon based DNA panel, simple single tube workflow |
| Hands-on time | ~3 hr |
| Input quantity | 10–80 ng DNA (20 ng recommended) |
| Instruments | MiSeq System, NextSeq 550 System, MiSeqDx in Research Mode, NextSeq 550Dx in Research Mode, MiSeq i100 Plus System, MiSeq i100 System |
| Mechanism of action | Multiplex PCR using tiled amplicon |
| Method | Targeted DNA sequencing, Amplicon sequencing |
| Nucleic acid type | DNA |
| Number of amplicons | 1 pool, 766 amplicons |
| Number of reactions | 24 reactions |
| On-target reads | 99.6% ± 0.2% |
| Specialized sample types | Blood, Low-input samples |
| Species category | Human |
| Target insert size | Average: 215 bp |
| Technology | Sequencing |
| Uniformity | 96.8% ±1.0% |
| Variant class | Single nucleotide variants (SNVs), Insertions-deletions (indels), Copy number variants (CNVs) |
Pillar oncoReveal panels require the use of a Pillar index kit. Pick your preferred number of reactions.
Pillar oncoReveal Myeloid Panel
A dedicated support section is not currently available for this product
| Pillar oncoReveal Myeloid Panel | AmpliSeq for Illumina Myeloid Panel | Pillar oncoReveal Essential MPN Panel | |
|---|---|---|---|
| Assay time | 48 hours sample to report | 5.5 – 7.5 hours (library prep only; doesn't include library quantification, normalization, or pooling time) | 48 hours sample to report |
| Cancer type | Hematologic | Hematologic | Hematologic |
| Description | 58-gene amplicon based DNA panel, simple single tube workflow | Targeted panel to study 40 DNA genes, 29 RNA fusion driver genes, and 5 gene expression levels associated with myeloid cancers. | A targeted gene panel focused on mutations affecting MPL, JAK2, and CALR, simple single tube workflow |
| Hands-on time | ~3 hr | < 1.5 hr | ~3 hr |
| Input quantity | 10–80 ng DNA (20 ng recommended) |
20 ng high-quality DNA; 10 ng high-quality RNA (10 ng recommended per pool) |
10–80 ng DNA (20 ng recommended) |
| Instruments | MiSeq System, NextSeq 550 System, MiSeqDx in Research Mode, NextSeq 550Dx in Research Mode, MiSeq i100 Plus System, MiSeq i100 System | MiSeq System, MiniSeq System | MiSeq System, NextSeq 550 System, MiSeqDx in Research Mode, NextSeq 550Dx in Research Mode, MiSeq i100 Plus System, MiSeq i100 System |
| Mechanism of action | Multiplex PCR using tiled amplicon | Multiplex PCR using tiled amplicon | |
| Method | Targeted DNA sequencing, Amplicon sequencing | Targeted DNA sequencing, Amplicon sequencing, Targeted RNA sequencing | Targeted DNA sequencing, Amplicon sequencing |
| Nucleic acid type | DNA | DNA, RNA | DNA |
| Number of amplicons | 1 pool, 766 amplicons | 3 genes, 7 amplicons | |
| Number of reactions | 24 reactions | 48 reactions per kit | |
| On-target reads | 99.6% ± 0.2% | 99.9% ± 0.0% | |
| Specialized sample types | Blood, Low-input samples | Blood, Not FFPE-compatible, Bone marrow | Blood, Low-input samples |
| Species category | Human | Human | Human |
| Target insert size | Average: 215 bp | Average: 167bp | |
| Technology | Sequencing | Sequencing | Sequencing |
| Uniformity | 96.8% ±1.0% | 100% | |
| Variant class | Single nucleotide variants (SNVs), Insertions-deletions (indels), Copy number variants (CNVs) | Single nucleotide polymorphisms (SNPs), Gene fusions, Somatic variants, Insertions-deletions (indels) | Somatic variants, Single nucleotide variants (SNVs), Insertions-deletions (indels) |
Pillar oncoReveal Myeloid Panel interrogates 58 genes from DNA.
Pillar oncoReveal Myeloid Panel specifications for DNA variant interrogation of 58 genes from blood.
oncoReveal™ Myeloid Panel
HDA-MY-1001-24
oncoReveal™ Myeloid Panel
Indices PI501-8, PI701-4 (32 combinations, 96 reactions)
IDX-PI-1001-96
Indices PI501-8, PI701-4 (32 combinations, 96 reactions)
List Price:
Discounts:
Kit D, indices PI501-8, PI701-12
IDX-PI-1004-192
Kit D, indices PI501-8, PI701-12
List Price:
Discounts:
Showing of
Product
Qty
Unit Price
Product
Catalog ID
Quantity
Unit price
Simplified operations, advanced chemistry, and onboard informatics provide an easy-to-use, fast, and flexible instrument supporting a broad range of applications.
Operationalize informatics and drive scientific insights with Illumina Connected Analytics. Contact us for information on pricing, subscriptions, and more.
Reagents for the MiSeq i100 Series feature easy-to-use cartridges and multiple flow cell configurations for flexible sequencing options.
A robust assay targeting key mutations in MPL, JAK2, and CALR genes, utilizing single-tube SLIMamp workflow for fast library prep and turnaround time.
Comprehensive gene fusion detection covering 507 genes from FFPE and other cancer research samples.
Target 1385 cancer genes for gene expression, variant, and fusion detection studies in many RNA sample types, including blood, bone marrow, and FFPE tissue.
Targeted DNA and RNA research panel investigating 52 genes with known relevance to solid tumors.
Reach out for information about our products and services, or get answers to questions about our technology.
Your email address is never shared with third parties.
